Lv1
50 积分 2025-08-01 加入
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
4天前
已完结
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
11天前
已完结
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models
1个月前
已完结
Activatable near-infrared fluorescent probes for targeting the tumor microenvironment in cancer theranostics
1个月前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
2个月前
已完结
PLASMIN‐ACTIVATED ANTICANCER PRODRUGS
2个月前
已完结
Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment
2个月前
已完结
Triggered Cascade-Activation Nanoplatform to Alleviate Hypoxia for Effective Tumor Immunotherapy Guided by NIR-II Imaging
2个月前
已完结
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
2个月前
已完结
Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
2个月前
已完结
皖公网安备34019202002308
